South America Malaria Treatment Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Treatment (Prescription Medications, Vaccines, Diagnostic Tests, and Others), Drug Type (Branded and Generic), Route of Administration (Oral and Parenteral & Intravenous), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and End User (Hospitals, Specialty Clinics, Homecare, and Others)

The South America malaria treatment market is expected to grow from US$ 71.79 million in 2022 to US$ 98.53 million by 2028. It is estimated to register a CAGR of 5.4% from 2022 to 2028.

Rapid Diagnostic Tests is Driving the South America Malaria Treatment Market

RDTs for malaria can improve the quality of management of the disease. RDTs are proven to be highly affordable and effective for public health programs implemented in low-resource settings. RDTs are widely used in remote areas with limited access to microscopy services. As a result, there has been a rapid rise in the demand for RDTs for malaria. Several RDTs have been developed to test the presence of malaria parasites in blood South Americaples. Identifying and successfully treating malaria in low transmission areas is critical to reduce transmission and achieve complete elimination of the disease. Many companies are engaged in developing a wide range of RDTs with high sensitivities. So, growing rapid diagnostic tests is expected to drive the South America malaria treatment market growth across the region.

South America Malaria Treatment Market Overview

The South America malaria treatment market is categorized into Brazil, Argentina, and the Rest of South America. Brazil held the substantial share in the market during forecast period. Malaria has always been a major public health concern in Brazil. The early history of malaria in Brazil and measures for its control has been powered by the forced relocation of Africans as enslaved people and the colonization of the Europeans. The immigrants brought malaria to different areas of Brazil. In Brazil, malaria is caused by three species of Plasmodium—P. vivax (which accounts for 83.7% of the registered cases), P. falciparum (causing 16.3% of the cases), and P. malariae (a small proportion of cases). The Brazilian government launched the National Malaria Elimination Plan, intending to reduce the number of local malaria cases to less than 68,000 by 2025 and the number of deaths to zero by 2030, as well as eliminate the disease in Brazil by 2035. Brazil is a country that houses the Amazon rainforest, from where most of the malaria cases come. Approximately 99.9% of transmissions in Brazil occur in the Amazon area and 80% in 33 cities.

In 2021, over 137.8 cases were reported. The Brazilian government is investing in treatment, pest control, and technical support to cities and states while also training personnel. The Elimination Plan will work through the Brazilian Unified Health System, based on free diagnosis and treatment, decentralized actions for diagnostic and wide coverage treatment, and using online information systems, multi-sector partnerships, and research networks. On October 30, 2019, GSK Brazil and MMV announced that the Brazilian Health Regulatory Agency (AVINSA) had granted the Marketing Authorization Approval under propriety review for the single dose tafenoquine for the medical cure of plasmodium vivax malaria in 16-year-old patients and for the older who are receiving chloroquine for the acute P. vivax infection. Jose Carlos Felner, the president of the GSK’s pharmaceutical division in Brazil, said that the approval of tafenoquine in the country is an important step in the fight against neglected diseases such as malaria. This will increase the demand for malaria treatment in Brazil and help eradicate the disease. Thus, the growing technical support by the Brazilian government can fuel the growth of the market.

South America Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

SAM Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

South America Malaria Treatment Market Segmentation

The South America malaria treatment market is segmented based on treatment, drug type, route of administration, distribution channel, end user, and country.

Based on treatment, the South America malaria treatment market is segmented into prescription medications, vaccines, diagnostic tests, and others. The diagnostic tests segment held the largest market share in 2022. The prescription medications segment is further categorized into chloroquine phosphate, artemisinin-based combination therapies (ACTs), atovaquone-proguanil, quinine sulfate (qualaquin) with doxycycline, primaquine phosphate, and others.

Based on drug type, the South America malaria treatment market is bifurcated into branded and generic. The generic segment held a larger market share in 2022.

Based on route of administration, the South America malaria treatment market is bifurcated into oral and parenteral & intravenous. The oral segment held a larger market share in 2022.

Based on distribution channel, the South America malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022.

Based on end user, the South America malaria treatment market is segmented into hospitals, specialty clinics, homecare, and others. The hospitals segment held the largest market share in 2022.

Based on country, the South America malaria treatment market has been categorized into Brazil, Argentina, and the Rest of South America. Our regional analysis states that the Rest of South America dominated the market in 2022.

AdvaCare Pharma USA LLC, Cipla Ltd, GSK Plc, Lupin Ltd, Novartis AG, Sanofi SA, Sun Pharmaceutical Industries Ltd, Viatris Inc, and Zydus Healthcare Ltd are among the leading companies operating in the South America malaria treatment market.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 South America Malaria Treatment Market – By Treatment

1.3.2 South America Malaria Treatment Market – By Drug Type

1.3.3 South America Malaria Treatment Market – By Route of Administration

1.3.4 South America Malaria Treatment Market – By Distribution Channel

1.3.5 South America Malaria Treatment Market – By End User

1.3.6 South America Malaria Treatment Market– By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South America Malaria Treatment Market– Market Landscape

4.1 Overview

4.2 South America PEST Analysis

4.3 Experts Opinion

5. South America Malaria Treatment Market – Key Market Dynamics

5.1 Market Drivers.

5.1.1 Government and Private Sector’s Initiatives to Raise Awareness About Malaria

5.2 Market Restraints

5.2.1 Counterfeit Antimalarial Drugs and Subsequent Drug Resistance

5.3 Market Opportunities

5.3.1 Extending Pipeline of New Drugs and Vaccines

5.4 Future Trends

5.4.1 Rapid Diagnostic Tests

5.5 Impact Analysis

6. Malaria Treatment Market– South America Analysis

6.1 South America Malaria Treatment Market Revenue Forecast and Analysis

7. South America Malaria Treatment Market Analysis – By Treatment

7.1 Overview

7.2 South America Malaria Treatment Market, By Treatment 2021 & 2028 (%)

7.3 Prescription Medications

7.3.1 Overview

7.3.2 Prescription Medication Market Revenue and Forecast to 2028 (US$ Mn)

7.3.3 Chloroquine Phosphate

7.3.3.1 Overview

7.3.3.2 Chloroquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)

7.3.4 Artemisinin- based Combination Therapies (ACTs)

7.3.4.1 Overview

7.3.4.2 Artemisinin- based Combination Therapies (ACTs) Market Revenue and Forecast to 2028 (US$ Mn)

7.3.5 Atovaquone-Proguanil

7.3.5.1 Overview

7.3.5.2 Atovaquone-Proguanil Market Revenue and Forecast to 2028 (US$ Mn)

7.3.6 Quinine Sulphate (Qualaquin) with Doxycycline

7.3.6.1 Overview

7.3.6.2 Quinine Sulphate (Qualaquin) with Doxycycline Market Revenue and Forecast to 2028 (US$ Mn)

7.3.7 Primaquine Phosphate

7.3.7.1 Overview

7.3.7.2 Primaquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)

7.3.8 Others

7.3.8.1 Overview

7.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

7.4 Vaccines

7.4.1 Overview

7.4.2 Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

7.5 Diagnostic Tests

7.5.1 Overview

7.5.2 Diagnostic Tests Market Revenue and Forecast to 2028 (US$ Mn)

7.6 Others

7.6.1 Overview

7.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8. South America Malaria Treatment Market Analysis – By Drug Type

8.1 Overview

8.2 South America Malaria Treatment Market, By Drug Type 2021 & 2028 (%)

8.3 Branded

8.3.1 Overview

8.3.2 Branded Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Generics

8.4.1 Overview

8.4.2 Generics Market Revenue and Forecast to 2028 (US$ Mn)

9. South America Malaria Treatment Market Analysis – By Route of Administration

9.1 Overview

9.2 South America Malaria Treatment Market, By Route of Administration 2021 & 2028 (%)

9.3 Oral

9.3.1 Overview

9.3.2 Oral Market Revenue and Forecast to 2028 (US$ Mn)

9.4 Parenteral and Intravenous Mode

9.4.1 Overview

9.4.2 Parenteral and Intravenous Mode Market Revenue and Forecast to 2028 (US$ Mn)

10. South America Malaria Treatment Market Analysis – By Distribution Channel

10.1 Overview

10.2 South America Malaria Treatment Market, By Distribution Channel 2021 & 2028 (%)

10.3 Direct Tender

10.3.1 Overview

10.3.2 Direct Tender Market Revenue and Forecast to 2028 (US$ Mn)

10.4 Hospital Pharmacies

10.4.1 Overview

10.4.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)

10.5 Retail Pharmacies

10.5.1 Overview

10.5.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)

10.6 Online Pharmacies

10.6.1 Overview

10.6.2 Online Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)

10.7 Others

10.7.1 Overview

10.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

11. South America Malaria Treatment Market Analysis – By End User

11.1 Overview

11.2 South America Malaria Treatment Market, By End User 2021 & 2028 (%)

11.3 Hospitals

11.3.1 Overview

11.3.2 Hospitals Market Revenue and Forecast to 2028 (US$ Mn)

11.4 Specialty Clinics

11.4.1 Overview

11.4.2 Specialty Clinics Market Revenue and Forecast to 2028 (US$ Mn)

11.5 Homecare

11.5.1 Overview

11.5.2 Homecare Market Revenue and Forecast to 2028 (US$ Mn)

11.6 Others

11.6.1 Overview

11.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

12. South America Malaria Treatment Market – Country Analysis

12.1 Overview

12.1.1 South America: Malaria Treatment Market, by Country, 2021 & 2028 (%)

12.1.1.1 Brazil: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

12.1.1.1.1 Brazil: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

12.1.1.1.2 Brazil: Malaria Treatment Market, by Treatment, 2019 – 2028 (US$ Million)

12.1.1.1.2.1 Brazil: Malaria Treatment Market, by Prescription medications, 2019 – 2028 (US$ Million)

12.1.1.1.3 Brazil: Malaria Treatment Market, by Drug Type, 2019 – 2028 (US$ Million)

12.1.1.1.4 Brazil: Malaria Treatment Market, by Route of Administration, 2019 – 2028 (US$ Million)

12.1.1.1.5 Brazil: Malaria Treatment Market, by Distribution Channel, 2019 – 2028 (US$ Million)

12.1.1.1.6 Brazil: Malaria Treatment Market, by End User, 2019 – 2028 (US$ Million)

12.1.1.2 Argentina: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

12.1.1.2.1 Argentina: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

12.1.1.2.2 Argentina: Malaria Treatment Market, by Treatment, 2019 – 2028 (US$ Million)

12.1.1.2.2.1 Argentina: Malaria Treatment Market, by Prescription Medications, 2019 – 2028 (US$ Million)

12.1.1.2.3 Argentina: Malaria Treatment Market, by Drug Type, 2019 – 2028 (US$ Million)

12.1.1.2.4 Argentina: Malaria Treatment Market, by Route of Administration, 2019 – 2028 (US$ Million)

12.1.1.2.5 Argentina: Malaria Treatment Market, by Distribution Channel, 2019 – 2028 (US$ Million)

12.1.1.2.6 Argentina: Malaria Treatment Market, by End User, 2019 – 2028 (US$ Million)

12.1.1.3 Rest of South America: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

12.1.1.3.1 Rest of South America: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

12.1.1.3.2 Rest of South America: Malaria Treatment Market, by Treatment, 2019 – 2028 (US$ Million)

12.1.1.3.2.1 Rest of South America: Malaria Treatment Market, by Prescription Medications, 2019 – 2028 (US$ Million)

12.1.1.3.3 Rest of South America: Malaria Treatment Market, by Drug Type, 2019 – 2028 (US$ Million)

12.1.1.3.4 Rest of South America: Malaria Treatment Market, by Route of Administration, 2019 – 2028 (US$ Million)

12.1.1.3.5 Rest of South America: Malaria Treatment Market, by Distribution Channel, 2019 – 2028 (US$ Million)

12.1.1.3.6 Rest of South America: Malaria Treatment Market, by End User, 2019 – 2028 (US$ Million)

13. Industry Landscape

13.1 Overview

13.2 Inorganic Growth Strategies

13.2.1 Overview

13.3 Organic Growth Strategies

13.3.1 Overview

14. Company Profiles

14.1 Zydus Healthcare Ltd

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Sun Pharmaceutical Industries Ltd

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Sanofi SA

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 GSK Plc

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Novartis AG

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Cipla Ltd

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Viatris Inc

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Lupin Ltd

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 AdvaCare Pharma USA LLC

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. South America Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Table 2. Brazil: Malaria Treatment Market, by Treatment– Revenue and Forecast to 2028 (US$ Million)

Table 3. Brazil: Malaria Treatment Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 4. Brazil: Malaria Treatment Market, by Drug Type– Revenue and Forecast to 2028 (US$ Million)

Table 5. Brazil: Malaria Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 6. Brazil: Malaria Treatment Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)

Table 7. Brazil: Malaria Treatment Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 8. Argentina: Malaria Treatment Market, by Treatment– Revenue and Forecast to 2028 (US$ Million)

Table 9. Argentina: Malaria Treatment Market, by Prescription Medications – Revenue and Forecast to 2028 (US$ Million)

Table 10. Argentina: Malaria Treatment Market, by Drug Type– Revenue and Forecast to 2028 (US$ Million)

Table 11. Argentina: Malaria Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 12. Argentina: Malaria Treatment Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)

Table 13. Argentina: Malaria Treatment Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 14. Rest of South America: Malaria Treatment Market, by Treatment– Revenue and Forecast to 2028 (US$ Million)

Table 15. Rest of South America: Malaria Treatment Market, by Prescription Medications – Revenue and Forecast to 2028 (US$ Million)

Table 16. Rest of South America: Malaria Treatment Market, by Drug Type– Revenue and Forecast to 2028 (US$ Million)

Table 17. Rest of South America: Malaria Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 18. Rest of South America: Malaria Treatment Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)

Table 19. Rest of South America: Malaria Treatment Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 20. Recent Inorganic Growth Strategies

Table 21. Recent Organic Growth Strategies in the Malaria Treatment Market

Table 22. Glossary of Terms

LIST OF FIGURES

Figure 1. South America Malaria Treatment Market Segmentation

Figure 2. South America Malaria Treatment Market Segmentation, By Country

Figure 3. South America Malaria Treatment Market Overview

Figure 4. South America Malaria Treatment Market, By Distribution Channel

Figure 5. South America Malaria Treatment Market, By Country

Figure 6. South America PEST Analysis

Figure 7. South America Malaria Treatment Market impact analysis of driver and restraints

Figure 8. South America Malaria Treatment Market – Revenue Forecast and Analysis

Figure 9. South America Malaria Treatment Market, by Treatment 2021 & 2028 (%)

Figure 10. Prescription Medication: South America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. Chloroquine Phosphate: South America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. Artemisinin- based Combination Therapies (ACTs): South America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13. Atovaquone-Proguanil: South America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. Quinine Sulphate (Qualaquin) with Doxycycline: South America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. Primaquine Phosphate: South America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16. Others: South America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. Vaccines: South America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. Diagnostic Tests: South America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19. Others: South America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. South America Malaria Treatment Market, by Drug Type 2021 & 2028 (%)

Figure 21. Branded: South America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22. Generics: South America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23. South America Malaria Treatment Market, by Route of Administration 2021 & 2028 (%)

Figure 24. Oral: South America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25. Parenteral and Intravenous Mode: South America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. South America Malaria Treatment Market, by Distribution Channel 2021 & 2028 (%)

Figure 27. Direct Tender: South America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28. Hospital Pharmacies: South America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. Retail Pharmacies: South America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 30. Online Pharmacies: South America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 31. Others: South America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 32. South America Malaria Treatment Market, by End User 2021 & 2028 (%)

Figure 33. Hospitals: South America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 34. Specialty Clinics: South America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 35. Homecare: South America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 36. Others: South America Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 37. South America: Malaria Treatment Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 38. South America Malaria Treatment Market, by Country, 2021 & 2028 (%)

Figure 39. Brazil: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 40. Argentina: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 41. Rest of South America: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South America malaria treatment market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South America malaria treatment market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South America market trends and outlook coupled with the factors driving the malaria treatment market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
South America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
South and Central America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission,..	May 2022
South and Central America In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syring..	May 2022

Purchase Options

Single User License

$3000

$2400

Site License

$4000

$3200

Enterprise License

$5000